Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation

DOI: 10.6515/ACS.201901_35(1).20180817A

Keywords: Anticoagulant, Dabigatran, Death, Effectiveness, Rivaroxaban, Safety

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text